|
 |
|
|
|||
|
 |
|
Jan. 10, 2024 Source: Indigo Ag news release CAMBRIDGE, Mass. - Flagship Pioneering, the bioplatform innovation company, and Indigo Ag, an innovative leader and trusted partner in sustainable agriculture, today announced that Dean Banks will join Flagship Pioneering as CEO-Partner and CEO of Indigo Ag, effective February 1, 2024. Banks will also continue as an Indigo board member, a role he has held since July 2022.
During his tenure, Hovsepian was responsible for successfully producing the world's first crop of registry-issued ag carbon credits at scale, expanding the company's industry-leading biological seed treatments, and the ongoing development and deployment of second-generation digital merchandising solutions. "On behalf of the Board of Directors, I would like to thank Ron for his leadership in taking Indigo to a new level of performance and growth and laying the foundation for its forward path in becoming the undisputed leader in the transformation to regenerative agriculture," said Robert Berendes, Ph.D., Chairman of the Board, Indigo Ag and Executive Partner, Flagship Pioneering. "We are delighted Ron will continue to contribute to Indigo's success as a board member and an advisor to the CEO." Berendes continued, "Dean has been a strategic and deeply engaged board member for Indigo, drawing on his extensive experience as an entrepreneur, technologist, innovator, and business executive. He is an energizing leader and visionary, and I am confident he will steward the company into this next critical phase of growth and profitability, and ultimately realize the full potential of the Indigo platform for companies, farmers, and the planet." "Dean brings entrepreneurial and operational experience and excellence to Indigo and an extensive track record in building value for life sciences, tech, and food companies, and he joins at an exciting time, given the recent close of the company's latest financing round," said Noubar Afeyan, Founder and CEO of Flagship Pioneering and Co-Founder of Indigo Ag. "His unique background makes him well-positioned to realize Indigo's bold ambitions and also to contribute to Flagship's growing sustainability portfolio." "I'm thrilled to take on the role of CEO of Indigo Ag. Over the last year on the board, I have witnessed the tremendous investment we've made to build scientifically validated digital sustainability tools and biological products that farmers, agribusiness, our CPG partners, and our planet urgently need," said Dean Banks, Incoming CEO of Indigo Ag and CEO-Partner of Flagship Pioneering. "Indigo's solutions are delivering on their promise to help make our farmers more successful today, driving higher yields and new revenue streams while helping them nurture their soil for better tomorrows. The company is uniquely positioned as a trusted, independent partner impacting millions of acres today across the agricultural value chain. I look forward to working with the team to take the company to the next level as we scale its growth and impact." About Dean Banks Banks most recently served as President and CEO of Tyson Foods where he was responsible for charting the long-term vision and transformation plan for the company including integration of advanced technologies like artificial intelligence, robotics, sustainable supply chain solutions and development of alternative proteins throughout its operations. During his four-year tenure with the company, he also served on the Board and executive leadership team. Banks joined Tyson from the high-tech incubator at Alphabet, the company formerly known as Google [X], where he served on the leadership team and led moonshot projects across multiple industries including sustainable food (as co-founder of Tidal) and robotics (as co-founder of Intrinsic). Banks was previously managing partner of SEED Ventures, a group investing in and developing early-stage healthcare technologies. He also has served as a consultant to Cleveland Clinic Innovations, SVP of Business Development and Strategic Marketing at OrthoHelix, co‐founder and CEO of Connective Orthopedics, and Vice President at Highland Capital Partners. He currently serves on the Boards of Vergent Bioscience (where he was a co-founder and founding CEO), on the Advisory Board of Shiru, and is a Sr. Advisor at Advent International. Banks served as a former platoon sergeant and squad leader in the U.S. Marine Corps. He holds a Bachelor of Arts from Miami University and a Master of Business Administration from the Harvard Business School. About Indigo Ag Indigo Ag is the sustainable agriculture partner that helps farmers and agribusinesses optimize today's yields and profitability, while nourishing the soil for better tomorrows and helping corporations reach their sustainability goals. By harnessing science and technology, Indigo Ag's sustainability programs unlock access to high value revenue streams while promoting practices that help land keep its value for future generations. Indigo is currently the only company offering corporations high quality agricultural carbon credits and scope 3 emissions reductions at scale. Our innovative biologicals boost plant growth to help maximize yields, even in tough conditions. And their state-of-the-art digital software facilitates greater efficiency, accuracy and profitability for crop transactions. Founded in 2013, Indigo Ag is focused on creating more profitable farmers and more sustainable companies. Operating across 14 countries, the company is delivering on its mission of harnessing nature to help farmers sustainably feed the planet. About Flagship Pioneering Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. To date, Flagship has deployed over $3.4 billion in capital toward the founding and growth of its pioneering companies alongside more than $26 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises over 40 companies, including Denali Therapeutics (NASDAQ: DNLI), Foghorn Therapeutics (NASDAQ: FHTX), Generate:Biomedicines, Inari, Indigo Agriculture, Moderna (NASDAQ: MRNA), Omega Therapeutics (NASDAQ: OMGA), Sana Biotechnology (NASDAQ: SANA), Seres Therapeutics (NASDAQ: MCRB) and Tessera Therapeutics. Tweet |
|
|
|
|
|
|
|
|
|||||||||||||
